EXHIBIT 99-2


                           ACCUIMAGE DIAGNOSTICS CORP.
                               400 GRANDVIEW DRIVE
                          SOUTH SAN FRANCISCO, CA 94080
                               STOCK SYMBOL: AIDP


FOR IMMEDIATE RELEASE

ACCUIMAGE ANNOUNCES ADDITION TO ITS BOARD OF DIRECTORS
SOUTH SAN FRANCISCO, CALIF. - APRIL 23, 2002 -


AccuImage Diagnostics Corp. announces that Hirsch Handmaker, M.D. has joined the
company's Board.

Dr. Handmaker earned his Bachelor of Science degree at The University of Arizona
and his M.D. at The University of Southern  California  College of Medicine.  He
was a founder,  President  and  Chairman of the Boards of  RadPharm,  Inc.,  and
Diagnostic  Networks,  Inc.,  was a  member  of the  Board of  Directors  of The
Cyclotron  Corporation  and Diatide,  Inc.,  has been a consultant or advisor to
various  other  public and  private  companies,  and served as a Director of the
Society of Nuclear Medicine Education and Research Foundation. He is the Founder
and President of Healthcare  Technology  Group, a management and consulting firm
specializing in providing  technical and business  advice to investors,  private
and  public  corporations,   hospitals,   medical  practices,   and  individuals
interested  in the health  care and medical  technology  business  sectors.  Dr.
Handmaker  served as  Executive  Director  of the Arizona  Institute  of Nuclear
Medicine and Medical Director of Papago Imaging, both in Phoenix,  Arizona, from
1994 to 1997.  He  previously  was  Vice-Chairman  of the  Department of Nuclear
Medicine,  California Pacific Medical Center and Director of Nuclear Medicine at
Children's  Hospital  of San  Francisco  for 22  years  prior to his  return  to
Arizona.  He is a diplomat  of the  American  Boards of  Radiology  and  Nuclear
Medicine  and a Fellow of the  American  College of Nuclear  Physicians.  He has
authored and  co-authored  over fifty  original  publications  and two textbooks
concerned with nuclear medicine and diagnostic imaging.  Dr. Handmaker currently
serves as Chairman and Acting CEO of VirtuRad,  serves on The Advisory  Board of
The Arizona Cancer Center and is  Chairperson  of the Steering  Committee of the
Women's Cancer Prevention arm of The Arizona Cancer Center.

In  announcing  this  addition,  Dr.  Leon  Kaufman,  AccuImage  CEO  said " Dr.
Handmaker is a long term friend and associate,  an individual  well respected in
the radiologic community for his clinical and business acumen, a man with vision
and feet planted  solidly on the ground.  Hirsch brings acute  professional  and
business  insights  to our  Board,  and will help us direct  growth and find new
opportunities  for the  capabilities  that we have built up during  last  year's
growth phase", Dr. Kaufman concluded.

AccuImage is engaged in the  development,  marketing and support of software for
visualization,  analysis and management of medical imaging data, particularly in
support of the imaging  screening  market,  a market that is growing even faster
than the traditional  imaging market.  The software brings value by reducing the
time the  physician  needs for  reviewing  and  reporting  cases,  enhancing the
interpretation of studies, and providing 3-D images for marketing, promotion and
patient  information.  Efficiency  gains and cost savings are  realized  through
automated  reporting  tools  incorporating  expert  knowledge,  and by providing
hardware and software  for  distribution  of the images and reports via internal
networks as well as internet  transmission  to remote  locations,  to  referring
physicians and to patients.  The Company is now expanding its markets  through a
three-pronged  approach:  the generation of automated report  generators for new
applications,  including  whole body  screening;  the sale of  upgrades  and new
products  to  existing  customers;   and  the  provision  of  quality  assurance
accreditation support services needed for demonstrating compliance with upcoming
recommendations  from the American  College of Radiology  and other  accrediting
bodies.   For  company   information  please  visit  the  AccuImage  website  at
www.accuimage.com.
_________________


<PAGE>


Except for the historical information contained herein, the matters discussed in
this news  release  may  contain  forward-looking  statements  that are based on
current  expectations  and  estimates  about  the  industry  in which  AccuImage
operates,  the estimated impact of certain  technological  advances,  as well as
management's beliefs and assumptions. It is important to note that the Company's
actual   results  could  differ   materially   from  those   projected  in  such
forward-looking  statements.  The  factors  that could cause  actual  results to
differ  materially  include,  among  others:  reliance on product  distributors;
competition  in the  diagnostic  imaging  market;  failure  to  improve  product
reliability or introduce new product models and enhancements;  determinations by
regulatory  and  administrative  government  authorities;  and the risk  factors
listed from time to time in the  Company's  Securities  and Exchange  Commission
reports.


CONTACT:
AccuImage Diagnostics Corp. 650/875-0192 www.accuimage.com
Investor Relations: investors@accuimage.com
Leon Kaufman, Ph.D., CEO contact@accuimage.com